Medtronic, Inc. (MDT) PT Raised to $149 at UBS After Reiterating Organic Guidance Despite Headwinds
Tweet Send to a Friend
UBS analyst Matthew Taylor raised the price target on Medtronic, Inc. (NYSE: MDT) to $149.00 (from $145.00) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
